Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA

OBJECTIVES: Splenectomy is considered a therapeutic modality for several hematological diseases, although complications are possible. This study assessed the effects of splenectomy on various hematological disorders and the roles of prophylactic measures on postoperative outcomes. METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsalman, Mortadah H., Al Jabr, Faisal A., Eraqe, Samma T., Ali, Sayed I., Essa, Abdallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396056/
https://www.ncbi.nlm.nih.gov/pubmed/36050951
http://dx.doi.org/10.1016/j.jtumed.2022.02.010
_version_ 1784771843726508032
author Alsalman, Mortadah H.
Al Jabr, Faisal A.
Eraqe, Samma T.
Ali, Sayed I.
Essa, Abdallah
author_facet Alsalman, Mortadah H.
Al Jabr, Faisal A.
Eraqe, Samma T.
Ali, Sayed I.
Essa, Abdallah
author_sort Alsalman, Mortadah H.
collection PubMed
description OBJECTIVES: Splenectomy is considered a therapeutic modality for several hematological diseases, although complications are possible. This study assessed the effects of splenectomy on various hematological disorders and the roles of prophylactic measures on postoperative outcomes. METHODS: This was a cross-sectional study performed in KSA on adult patients with underlying non-malignant hematological disorders who had undergone splenectomy. RESULTS: This study examined 179 patients with various hematological disorders, 38 (21.1%) of whom had undergone a splenectomy. Of those 38 patients, more than two-thirds (73.7%) had an open splenectomy. The average hospital stay was 2–7 days, and no significant difference was observed between the open and laparoscopic approaches. Approximately 95% of the patients showed overall improvements in their condition after splenectomy. However, 26.3% of patients reported a recurrence or need for further treatment 1 year or more after splenectomy. Approximately 16% of patients had an increased incidence of postoperative infectious complications, particularly patients with sickle cell disease and beta thalassemia. More than half the patients who developed complications had not received vaccination preoperatively, whereas 44.4% of vaccinated patients experienced complications (p = 0.04). CONCLUSION: Splenectomy is considered a universal line of treatment for most non-malignant hematological diseases. Although splenectomy is an effective treatment, the reasons why patients with the same disease can have different responses remains unclear. Infection is a common postoperative complication, and vaccinations are underused. This study emphasizes the roles of patient education, scheduled vaccinations and proper selection of patients in the use of splenectomy for the treatment of non-malignant hematological diseases.
format Online
Article
Text
id pubmed-9396056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taibah University
record_format MEDLINE/PubMed
spelling pubmed-93960562022-08-31 Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA Alsalman, Mortadah H. Al Jabr, Faisal A. Eraqe, Samma T. Ali, Sayed I. Essa, Abdallah J Taibah Univ Med Sci Original Article OBJECTIVES: Splenectomy is considered a therapeutic modality for several hematological diseases, although complications are possible. This study assessed the effects of splenectomy on various hematological disorders and the roles of prophylactic measures on postoperative outcomes. METHODS: This was a cross-sectional study performed in KSA on adult patients with underlying non-malignant hematological disorders who had undergone splenectomy. RESULTS: This study examined 179 patients with various hematological disorders, 38 (21.1%) of whom had undergone a splenectomy. Of those 38 patients, more than two-thirds (73.7%) had an open splenectomy. The average hospital stay was 2–7 days, and no significant difference was observed between the open and laparoscopic approaches. Approximately 95% of the patients showed overall improvements in their condition after splenectomy. However, 26.3% of patients reported a recurrence or need for further treatment 1 year or more after splenectomy. Approximately 16% of patients had an increased incidence of postoperative infectious complications, particularly patients with sickle cell disease and beta thalassemia. More than half the patients who developed complications had not received vaccination preoperatively, whereas 44.4% of vaccinated patients experienced complications (p = 0.04). CONCLUSION: Splenectomy is considered a universal line of treatment for most non-malignant hematological diseases. Although splenectomy is an effective treatment, the reasons why patients with the same disease can have different responses remains unclear. Infection is a common postoperative complication, and vaccinations are underused. This study emphasizes the roles of patient education, scheduled vaccinations and proper selection of patients in the use of splenectomy for the treatment of non-malignant hematological diseases. Taibah University 2022-03-08 /pmc/articles/PMC9396056/ /pubmed/36050951 http://dx.doi.org/10.1016/j.jtumed.2022.02.010 Text en © 2022 [The Author/The Authors] https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Alsalman, Mortadah H.
Al Jabr, Faisal A.
Eraqe, Samma T.
Ali, Sayed I.
Essa, Abdallah
Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title_full Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title_fullStr Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title_full_unstemmed Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title_short Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
title_sort splenectomy perspective for non-malignant hematological disorders: a cross-sectional study in the eastern province of ksa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396056/
https://www.ncbi.nlm.nih.gov/pubmed/36050951
http://dx.doi.org/10.1016/j.jtumed.2022.02.010
work_keys_str_mv AT alsalmanmortadahh splenectomyperspectivefornonmalignanthematologicaldisordersacrosssectionalstudyintheeasternprovinceofksa
AT aljabrfaisala splenectomyperspectivefornonmalignanthematologicaldisordersacrosssectionalstudyintheeasternprovinceofksa
AT eraqesammat splenectomyperspectivefornonmalignanthematologicaldisordersacrosssectionalstudyintheeasternprovinceofksa
AT alisayedi splenectomyperspectivefornonmalignanthematologicaldisordersacrosssectionalstudyintheeasternprovinceofksa
AT essaabdallah splenectomyperspectivefornonmalignanthematologicaldisordersacrosssectionalstudyintheeasternprovinceofksa